Investment Banking Services that Drive Transformative Transactions

After growing Quartesian into one of the largest independent biometrics companies in the world, we realized the next chapter of our journey would require a strong financial partner, but finding the right partner would be a challenge. Crosstree put their expertise in the pharma services space to work for us, helping us identify Summit Partners – the perfect fit for all of our stakeholders. The resulting deal led to Quartesian becoming a foundational pillar in Veranex, the first concept-to-commercialization global service provider in medtech.

I really can’t speak highly enough of the expert, intelligent and dedicated advocacy of Crosstree that brought about a truly tremendous result for Ascent. The Crosstree team was superb in all aspects of setting up, negotiating and finalizing a really fantastic deal. We particularly appreciated their willingness to work flexibly with Ascent as we were undergoing considerable growing pains, especially related to financial management which was such a critical aspect. The Ascent team was really lucky and is very grateful for having had access to such expert, dedicated and adept support.

Crosstree was recommended to us by a trusted partner who had previously worked closely with them on successful deals. We are very pleased to have listened to this advice and have been guided and supported throughout the merger process over the last months. The team brought a strong understanding of our industry segment, finding an impressive list of prospective buyers, and then ensured that during the due diligence and closing phases we hit each of the critical milestones on time.

After growing Quartesian into one of the largest independent biometrics companies in the world, we realized the next chapter of our journey would require a strong financial partner, but finding the right partner would be a challenge. Crosstree put their expertise in the pharma services space to work for us, helping us identify Summit Partners – the perfect fit for all of our stakeholders. The resulting deal led to Quartesian becoming a foundational pillar in Veranex, the first concept-to-commercialization global service provider in medtech.